New agents for induction and postremission therapy of acute myeloid leukemia.
Larson
R A
RA
University of Chicago, IL 60637, USA.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004148:Dioxolanes / Q000627:therapeutic use; D000079982:Gemtuzumab; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D019772:Topotecan / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004148:Dioxolanes; C101579:monoclonal antibody M195; C074908:troxacitabine; D019772:Topotecan; D003596:Cytosine; D000079982:Gemtuzumab